INVENTORIES |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Classes of current inventories [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INVENTORIES [Text Block] |
5. INVENTORIES
The change in the allowance for impairment of inventory in the amount of $1,596,000 (March 31, 2025: $136,447) was recognized as an expense and included in cost of sales and includes a provision for excess graphene oxide of $1,701,900. The write-down primarily relates to aged graphene oxide inventory for which management no longer expects to realize amounts substantially in excess of nominal proceeds through sale. Accordingly, the affected inventory was written down to its estimated recoverable amount, which management determined to be nominal. The amount of inventories recognised as an expense and included in cost of sales for the year ended March 31, 2026 was $1,838,971, (2025: $644,610). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||